Fluid shear stress (FSS) is a critical regulator of cation transport in the collecting duct (CD). High-dietary sodium (Na) consumption increases urine flow, Na excretion, and prostaglandin E 2 (PGE2) excretion. We hypothesize that increases in FSS elicited by increasing tubular flow rate induce the release of PGE 2 from renal epithelial cells into the extracellular compartment and regulate ion transport. Media retrieved from CD cells exposed to physiologic levels of FSS reveal several fold higher concentration of PGE 2 compared with static controls. Treatment of CD cells with either cyclooxygenase-1 (COX-1) or COX-2 inhibitors during exposure to FSS limited the increase in PGE 2 concentration to an equal extent, suggesting COX-1 and COX-2 contribute equally to FSS-induced PGE 2 release. Cytosolic phospholipase A2 (cPLA2), the principal enzyme that generates the COX substrate arachidonic acid, is regulated by mitogen-activated proteinkinase-dependent phosphorylation and intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i), both signaling processes, of which, are activated by FSS. Inhibition of the ERK and p38 pathways reduced PGE 2 release by 53.3 Ϯ 8.4 and 32.6 Ϯ 11.3%, respectively, while antagonizing the JNK pathway had no effect. In addition, chelation of [Ca 2ϩ ]i limited the FSS-mediated increase in PGE 2 concentration by 47.5 Ϯ 7.5% of that observed in untreated sheared cells. Sheared cells expressed greater phospho-cPLA2 protein abundance than static cells; however, COX-2 protein expression was unaffected (P ϭ 0.064) by FSS. In microperfused CDs, COX inhibition enhanced flow-stimulated Na reabsorption and abolished flow-stimulated potassium (K) secretion, but did not affect ion transport at a slow flow rate, implicating that high tubular flow activates autocrine/paracrine PGE 2 release and, in turn, regulates flow-stimulated cation transport. In conclusion, FSS activates cPLA2 to generate PGE 2 that regulates flow-mediated Na and K transport in the native CD. We speculate that dietary sodium intake modulates tubular flow rate to regulate paracrine PGE 2 release and cation transport in the CD.
HIGH-SODIUM (HS) diets and attendant extracellular volume expansion induce intrarenal increases in prostaglandin (PG) synthesis, specifically PGE 2 (3, 17, 29, 31, 32) . PGE 2 is an abundant renal PG and is a potent inhibitor of sodium (Na) and water reabsorption in the inner medullary collecting duct (IMCD) (20) . Inhibition of PGE 2 synthesis is associated with avid renal Na absorption and hypertension, consistent with a critical role for PGE 2 in Na homeostasis and blood pressure regulation (29) . Moreover, salt-sensitive hypertension is linked to deficiencies in renal PGE 2 synthesis and homeostasis (9, 12, 22) . The physiologic and/or cellular triggers regulating PGE 2 synthesis and release in the CD that contribute to Na homeostasis are unknown. 1 In murine models of HS intake, enzymes that synthesize PGE 2 , including cyclooxygenase-1 (COX-1), COX-2, and microsomal prostaglandin E synthase-1 (mPGES-1), are increased (3) . The mechanism underlying this response is unclear; however, alterations in urine tonicity have been implicated (30, 31) . We hypothesized that fluid shear stress (FSS), accompanying high tubular flow rates elicited by HS feeding, triggers synthesis of PGE 2 and transcription/translation of the enzymes manufacturing PGE 2 . To corroborate the physiologic relevance of FSS-induced changes in PGE 2 availability on cation transport, COX-dependent Na and potassium (K) transepithelial flux were measured in microperfused CDs under slow and fast flow rates.
MATERIALS AND METHODS
Cell culture. Murine immortalized IMCD3 or mpk cortical CD (mpkCCD) cells were grown in DMEM/F12 (with 10% fetal bovine serum) or DMEM:Ham's F12 (with 60 nM sodium selenate, 5 g/ml transferrin, 2 mM glutamine, 50 nM dexamethasone, 1 nM tri-iodothyronine, 10 ng/ml epidermal growth factor, 5 g/ml insulin, 20 mM D-glucose, 2% fetal calf serum, and 20 mM HEPES), respectively, on 25-mm ϫ 75-mm slides or 40-mm glass coverslips and studied when they reached confluence between 3 and 7 days. We only used cells up to passage 15 due to the risk of genetic drift.
Induction of FSS. Cells grown on slides and coverslips were placed in laminar flow chambers (Glycotech or Bioptechs manufactured chamber, respectively) and maintained at 37°C and subject to shear of 0.4 dyn/cm 2 using phenol red-free, serum-free DMEM/F12 containing penicillin/streptomycin for varying durations. FSS was calculated based on Poiseulle's law; ϭ ␥ ϭ 6Q/a 2 b where ϭ wall stress (dyn/cm 2 ), ␥ ϭ shear rate (per s), ϭ apparent viscosity of the fluid (media at 37°C ϭ 0.76 cP), a ϭ channel height (cm), b ϭ channel width (cm), and Q ϭ volumetric rate (ml/s). Static control cells were exposed to the same solution and duration as sheared cells, but without exposure to FSS. Cells from the Glycotech chamber were then collected for total RNA or protein while intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i) was measured in cells placed in the Bioptechs chamber.
PGE 2 measurement. One milliliter of serum-and phenol red-free DMEM/F12 was incubated with either static or sheared cells for 1 h (19) . The conditioned media were collected and frozen at Ϫ80°C for measurement of PGE 2 at a later time. PGE2 concentration (pg/ml) was measured with a PGE2 enzyme immunoassay kit (Cayman Chemical), following the standard protocol enclosed with the kit, and PGE 2 concentration was normalized to the amount of cellular protein to which the conditioned media were exposed. If sheared or static cells were exposed to the inhibitor, the inhibitor was also present in the conditioned media.
Western blotting. Western blot analysis was performed as previously described (8) . Cellular protein lysates (30 to 100 g, depending on the abundance of the signal) were isolated as described above, resolved electrophoretically, and transferred to Immobilon filters (Millipore, Billerica, MA). Filters were blocked in 5% nonfat dried milk and 0.05% Tween and immunoblotted with a primary antibody (see Reagents). After being washed, blots were incubated with a horseradish peroxidase-conjugated secondary antibody (Sigma, St. Louis, MO) and bands were visualized by the West Pico enhanced chemiluminescence kit (Pierce, Rockford, IL). After the membrane was stripped and blocked, the blot was incubated with an anti-totalprotein, anti-actin, or anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-specific antibody and visualized using the same methods as the primary antibody.
Quantitative real-time PCR. RNA was extracted from cells and cDNA was synthesized using random primers (27) . Murine GAPDH was chosen as the internal positive reference control. qRT-PCR was performed as follows. In a 384-well plate, 0.2-l cDNA sample was added plus 8 l of a cocktail mix containing 0.05 l Platinum Taq DNA Polymerase, 1 l of 10ϫ PCR buffer, 1.1 l of 50 mM magnesium chloride, 0.1 l AmpErase uracil N-glycosylase (UNG), 0.2 l Gene Amp dNTPs with dUTP, 0.2 l passive reference ROX dye, 0.2 l (20 pM) forward and reverse primers, and 0.04 l Taqman probe. Taq DNA Polymerase and ROX were purchased from Invitrogen (Carslbad, CA) and AmpErase UNG and dNTPs with dUTP from Applied Biosystems (Foster City, CA). Nuclease-free water was added for a total volume of 10 l. Each plate was then covered with optical adhesive film and, after the initial steps of 50°C/2 min and 95°C/10 min, 40 cycles of 95°C/15 s (melt) and 60°C/1 min (anneal/ extend), detection was performed in an ABI Prism 7900HT using SDS 2.2.1, Sequence Detection System software.
Measurement of [Ca 2ϩ ]i. IMCD3 cells grown on 40-mm glass coverslips were incubated in serum-free DMEM/F12 media containing 25 M FURA-2AM (Molecular Probes, Eugene, OR), a cellpermeant Ca 2ϩ indicator dye, for 20 min. The cells were placed in a parallel plate-type laminar perfusion chamber (FCS2, Bioptechs, Butler, PA) and set on the stage of a Nikon Eclipse TE300 inverted epifluorescence microscope linked to a cooled Pentamax CCD camera (Princeton Instruments) interfaced with a digital imaging system (MetaFluor, Universal Imaging, Westchester, PA). The chamber temperature was maintained at 37°C with an FCS2 Temperature Controller (Bioptechs) and perfused using a FCS Micro-Perfusion Pump (Bioptechs). The shear generated across the monolayer was calculated using Poiseulle's law, as described above.
Cells in the laminar flow chamber were maintained in serum-and phenol red-free DMEM/F12 under no shear to confirm that baseline [Ca 2ϩ ]i was stable for 5 min. The pump rate was then abruptly increased to produce a shear of 0.4 dyn/cm 2 for ϳ10 min. Throughout the experiment, cells were alternately excited at 340 and 380 nm and images, acquired every 1 to 15 s, were digitized for subsequent analysis. At the conclusion of each experiment, an intracellular Ca 2ϩ calibration was performed using standard techniques (16) . Standard equations were used to calculate experimental values of Microperfusion of single tubules. Kidneys were removed via a midline incision, and single cortical CDs (CCDs) were dissected in cold (4°C) Ringer solution and microperfused in vitro as previously described (5) . Briefly, each isolated tubule was immediately transferred to a temperature-and O2/CO2-controlled specimen chamber, mounted on concentric glass pipettes, and perfused and bathed at 37°C with Burg's perfusate containing (in mM) 120 NaCl, 25 NaHCO3, 2.5 K2HPO4, 2.0 CaCl2, 1.2 MgSO4, 4.0 Na lactate, 1.0 Na3 citrate, 6.0 L-alanine, and 5.5 D-glucose, pH 7.4, 290 Ϯ 2 mosmol/kgH2O (5). During the 45-min equilibration period and thereafter, the perfusion chamber was continuously suffused with a gas mixture of 95% O2-5% CO2 to maintain the pH of the Burg's solution at 7.4 at 37°C. The bathing solution was continuously exchanged at a rate of 10 ml/h with a syringe pump (Razel, Stamford, CT).
Transport measurements were performed in the absence of transepithelial osmotic gradients, and thus water transport was assumed to be zero. Three or four samples of tubular fluid were collected under water-saturated light mineral oil by timed filling of a calibrated 30-nl volumetric constriction pipette at slow (ϳ1 nl·min Ϫ1 ·mm Ϫ1 ) and fast (ϳ5 nl·min Ϫ1 ·mm Ϫ1 ) flow rates. Indomethacin was added to the tubule during exposure to slow flow conditions. The K and Na concentrations of perfusate (C0) and collected tubular fluid (CL) were determined by helium glow photometry. The rates of K and Na transport (Jx; in pmol·min Ϫ1 ·mm Ϫ1 ) were calculated as follows: J ϭ (C0 Ϫ CL) ϫ VL/L, where VL is the rate of collection of tubular fluid determined from the time (in min) required to fill the precalibrated volumetric pipette and L is the tubule length in millimeters. To determine the concentration of Na and K delivered to the tubular lumen, ouabain (100 M) was added to the bath at the conclusion of each experiment to inhibit all active transport, and an additional three or four samples of tubular fluid were obtained for analysis. The rates of net transport (in pmol·min Ϫ1 ·mm tubular length Ϫ1 ) were calculated with standard flux equations, and the calculated ion fluxes were averaged to obtain a mean rate of ion transport for the CCD at each flow rate, as previously described (5). The flow rate was varied by adjusting the height of the perfusate reservoir. The sequence of flow rates was randomized within each group of tubules to minimize any bias induced by time-dependent changes in ion transport.
Reagents. Inhibitors were as follows: 10 M U0126 (Calbiochem, San Diego, CA), 10 M SB203580 (Cayman Chemical), 30 M SP600125 (2) (Calbiochem), 125 M indomethacin (14) (Sigma), 20 M BAPTA-AM (Invitrogen), 100 nM SC560 (Cayman Chemical), and 1 M CAY10404 (Cayman Chemical). Primers for qRT-PCR (Applied Biosciences) were as follows: COX-1 (Mm00477214_m1), COX-2 (Mm00478374_m1), Ptges-1 (Mm00452105_m1), and GAPDH (Mm99999915_g1); and antibodies were as follows: polyclonal antiphospho-Ser505-cPLA2 (1:500; Cell Signaling), polyclonal cPLA2 (1:500; Cell Signaling), rabbit polyclonal anti-phospho-p38 (1:1,000; Cell Signaling), rabbit polyclonal anti-COX-2 (1:1,000; Cayman Chemical), mouse monoclonal anti-actin (1:1,000; Cell Signaling), mouse monoclonal anti-GAPDH (1:4,000; Santa Cruz Biotechnology), and goat anti-rabbit conjugated to horseradish peroxidase (1:5,000; Sigma).
Statistics. Data are given as means Ϯ SE (n ϭ number of slides or CCDs). Statistical analyses were performed using unpaired t-tests (SigmaStat version 2.03; SPSS, San Rafael, CA) for cell culture experiments and between treated and untreated CCDs, and paired t-test before and after indomethacin treatment of CCDs.
RESULTS
Immortalized IMCD3 and mpkCCD cells were exposed to a FSS of 0.4 dyn/cm 2 or static conditions for 2 h. This level of FSS was chosen because previously we demonstrated that ). Both CD cell lines exposed to FSS release PGE 2 ; however, we focused on IMCD3 cells because others have reported that immunodetectable PGE 2 synthetic enzymes, including COX-1/2 and mPGES-1, were upregulated in the renal medulla of mice fed a HS diet (3, 31, 32) . To evaluate the contribution of COXs to FSS-induced PGE 2 release, sheared cells were treated with a COX-1 (SC560) or COX-2 (CAY10404) inhibitor and the FSS-induced increase in PGE 2 was measured in the perfusate (Fig. 1C) . The inhibitor data are presented as percent reduction compared with untreated sheared cells. COX-1 and COX-2 inhibition attenuated the PGE 2 concentration in the media by 62.0 Ϯ 8.4 and 70.0 Ϯ 2.7% compared with untreated sheared cells ( Fig. 1C ; *P Ͻ 0.05), respectively, suggesting that both COX isoforms contribute equally to FSSinduced PGE 2 synthesis. IMCD3 and mpkCCD cells were grown to confluence and exposed to 0.4 dyn/cm 2 of FSS or maintained under static condition for 2 h. Cells were incubated in culture media for 1 h, the conditioned media were collected, and PGE2 concentrations (pg/ml) were measured by enzyme immunoassay. The PGE2 concentration was normalized to the amount of cellular protein (pg·ml Cytosolic phospholipase A2 (cPLA2) activity is regulated by two signaling pathways: 1) increases in [Ca 2ϩ ] i (6, 11) and 2) mitogen-activated protein (MAP)-kinase-dependent serine 505 phosphorylation of cPLA2 (11) . Increases in [Ca 2ϩ ] i enhance translocation of cPLA2 to cellular membranes where it releases arachidonic acid (AA). cPLA2 activity is further augmented by MAP-kinase-dependent phosphorylation (13 We previously demonstrated that FSS increased the abundance of phospho-ERK and phospho-JNK in IMCD3 cells so we next tested whether FSS induces the abundance of phosphop38, also implicated in phosphorylating cPLA2 (8, 10) . Phospho-p38 abundance was greater in sheared (n ϭ 4) than static cells ( Fig. 3A ; n ϭ 5, P Ͻ 0.05) at 120 min. To identify which MAP-kinases regulate FSS-induced release of PGE 2 , sheared cells were incubated individually with U0126 (ERK pathway inhibitor), SB203580 (p38 pathway inhibitor), or SP600125 (JNK pathway inhibitor). U0126 and SB203580 reduced the PGE 2 concentration in the media by 53.3 Ϯ 8.4 and 32.6 Ϯ 11.3%, respectively, compared with shear-untreated controls ( Fig. 3B ; *P Ͻ 0.05) while SP600125 did not alter PGE 2 concentration (Fig. 3B) , suggesting a role for ERK and p38 but not JNK in FSS-mediated PGE 2 release.
We then tested whether FSS activates cPLA2 by phosphorylating serine 505. Cells exposed to FSS for 120 min expressed greater steady-state abundance of phospho-cPLA2 than static cells (Fig. 4A) , implicating the activation of cPLA2 and generation of AA in the FSS response. To test whether FSS alters the expression of the other genes involved in PGE 2 synthesis, the steady-state abundance of mRNAs encoding COX-1, COX-2, and mPGES-1 was measured in cells exposed to shear or static conditions. Expression of COX-1 and mPGES-1 mRNA was unaffected by FSS; however, COX-2 mRNA increased by 4.8 Ϯ 0.9-fold compared with static cells (Fig.  4B ; *P Ͻ 0.05). Next, lysates from cells exposed to FSS or static conditions for 2 h were immunoblotted with anti-COX-2 and anti-GAPDH antibodies and densitometric analysis was performed. In a single immunoblot (Fig. 4C) , COX-2 protein appeared to be similar between sheared and static cells; however, in six experiments in total, COX-2 abundance tended to be greater in sheared (Fig. 4D, n ϭ 6 ) than static (n ϭ 5, P ϭ 0.064) cells.
A HS diet induces CD COX gene and protein expression and urinary PGE 2 excretion while suppressing serum aldosterone to enhance Na excretion (3, 5). Estilo et al. (5) previously reported that flow-stimulated net Na absorption (J Na ) was blunted in microperfused CCDs isolated from rabbits fed a HS diet when compared with transport rates measured in tubules from animals fed a low-Na diet (5) . To test whether a flowinduced increase in PGE 2 synthesis/release in the CCD contributes to this blunted flow stimulation of J Na , J Na was measured in microperfused CCDs isolated from HS-fed rabbits before and after treatment with indomethacin. In a series of control untreated CCDs isolated from HS-fed rabbits, J Na increased about threefold from 13.4 Ϯ 3.9 to 38.8 Ϯ 4.8 pmol·min Ϫ1 ·mm Ϫ1 as the luminal flow rate was increased from a slow (ϳ1) to a fast (5 nl·min Ϫ1 ·mm Ϫ1 ) flow rate ( Fig. 5A , left; *P Ͻ 0.05); this increase in J Na was similar to that observed by Estilo et al. (5) Addition of indomethacin to another set of CCDs perfused at slow flow rates had no significant effect on J Na (16.2 Ϯ 2.5 vs. 17.0 Ϯ 1.5 pmol·min Ϫ1 ·mm
Ϫ1
). However, increasing the luminal flow rate in these indomethacin-treated CCDs to 5 nl·min Ϫ1 ·mm Ϫ1 led to a greater than fourfold increase in J Na to 63.2 Ϯ 2.5 pmol·min Ϫ1 ·mm Ϫ1 (n ϭ 4; @P Ͻ 0.05). This rate of Na absorption was significantly greater than that measured in control untreated CCDs perfused at a similar fast flow rate ($P Ͻ 0.05, via unpaired t-test). These data suggest that flow-stimulated PGE 2 synthesis/release in the CCD acts in an autocrine/paracrine fashion to blunt J Na and that this repression of J Na is abrogated when PGE 2 synthesis is inhibited by indomethacin. Measurement of net K secretion (J K ) in the ). However, in the presence of indomethacin flow-stimulated K secretion was abolished (Ϫ10.8 Ϯ 3.4 pmol·min Ϫ1 ·mm
; P ϭ not significant vs. J K in the same CCDs pefused at a slow flow rate).
In sum, inhibition of COX, and in particular PGE 2 synthesis, enhanced flow-stimulated J Na and inhibited flow-induced J K , previously shown to reflect activation of the BK channel, but was without effect on cation transport in CCDs isolated from HS-fed rabbits and perfused at slow flow rates (15, 26) . These results suggest that PGE 2 synthesis, stimulated in the CCD perfused at high tubular fluid flow rates, inhibits Na absorption and activates BK channel-mediated K secretion (14) .
DISCUSSION
Although biomechanical forces play important physiologic and pathophysiologic roles in the kidney (1, 4, 7, 18, 21, 25 ), our understanding of how biophysical forces influence cellular processes and signaling pathways is in its infancy. This paper focused on the effect of FSS on renal epithelial PGE 2 release and the local paracrine effects of PGE 2 on CD cation transport. We demonstrate FSS enhances 1) PGE 2 release through [Ca 2ϩ ] i and MAP-kinase-dependent signaling; 2) the abundance of phosphorylated serine 505 of cPLA, an activated form of cPLA2 that releases AA; and 3) the steady-state abundance of COX-2 mRNA, although COX-2 protein abundance was not statistically different. Moreover, in the setting of a HS diet, flow-stimulated cation transport was regulated by flow-stimulated, COX-dependent PGE 2 synthesis/release, permitting the independent regulation of Na reabsorption and K secretion. Activation of this important system would, thus, permit urinary K secretion in the face of HS diet and low serum aldosterone, which is expected to blunt K secretion.
Other investigators showed that stretch also may activate the eicosanoid system though cPLA2. In primary cultures of rabbit proximal tubular epithelial cells, cyclical stretch activated ERK-dependent phosphorylation of cPLA2 to release AA (1), similar to our suspected model of FSS activation of PGE 2 . Treatment with BAPTA-AM did not affect stretch-mediated AA release but chelation of extracellular Ca 2ϩ abrogated the stretch response (1) . On the other hand, BAPTA-AM in our FSS model reduced PGE 2 release by ϳ50%. These differences in response to BAPTA-AM may be related to differences in the "stretch" vs. "shear" signal that is generated by the mechanical force or simply to differences in epithelial cell type (proximal tubule vs. CD). Moreover, raising the tubular flow rate in microperfused tubules not only increases apical FSS, but it also leads to circumferential stretch of the CD epithelia (17) and from our current experiments we cannot quantify the contribution of stretch to PGE 2 -mediated cation transport.
In sum, our data add to the body of evidence that tubular flow and its hydrodynamic equivalent FSS are a physiologic trigger that activates autocrine/paracrine signaling systems in the CD to modulate cation transport. Recent evidence points to flow-triggered secretion of ATP (24), endothelin-1 (18), and 11,12 epoxyeicosatrienoic acid (11, 12 EET) (23) in the paracrine regulation of Na and K transport in the CD. However, this study is the first to demonstrate that a flow-stimulated paracrine factor is able to dissociate flow-stimulated Na and K transport in a nephron segment responsible for the final regulation of Na and K homeostasis. Of note is that Sun et al. (23) demonstrated that flow-stimulated K secretion was dependent on flow-induced 11,12 EET synthesis. We speculate that flow activation of cPLA2 is the principal mechanism by which 11,12 EET is synthesized since AA is the substrate for CYP-epoxygenase 2C23. This may reflect a common mechanism in the CD epithelia, in that increases in tubular flow rate activate cPLA2 and AA generation which forms the common substrate necessary for prostanoid, epoxyeicosatrienoic acid, lipoxin, leukotriene, and thromboxane synthesis. In conclusion, FSS-stimulated activation of cPLA2 and downstream PGE 2 synthesis/ release are critical regulators of cation transport in the CD, and FSS activation of cPLA2 may reflect a common mechanism by which to generate AA, a common substrate to generate many other eicosanoids.
